Search images on Google      Product Monograph

Active Ingredients:

• andusomeran, 0.1 MG/ML

DIN: 02541270

Dosage Form(s): DISPERSION

Route(s) of Administration: INTRAMUSCULAR

Description: 2.5 ML MULTIDOSE VIAL

Schedule: Schedule D

Company: MODERNA BIOPHARMA CANADA CORPORATION

ATC:

• J07 - VACCINES (ATC, WHO, Wiki)
• J07B - VIRAL VACCINES (ATC, WHO)
• J07BN - (ATC, WHO)
• J07BN01 - COVID-19, RNA-BASED VACCINE (WHO)

 

External Links for Spikevax Xbb.1.5:

Search on Google

• Spikevax Xbb.1.5 side effects
• Spikevax Xbb.1.5 dosage
• andusomeran side effects
• andusomeran dosage